Global Biotechnology -Yearly Update 2006

Published by: Cygnus Business Consulting and Research

Published: Jul. 1, 2007 - 42 Pages

Table of Contents

1. Industry Overview

1.1 Industry growth

1.1.2 Industry concentric

1.1.3 Industry analysis

1.1.4 R&D expenditure

1.1.5 Number of players

1.1.6 Financial flow

1.2 References

2. Major Markets

2.1 Economy

2.2 Global market

2.3. North America

2.3.1 Biotechnology Industry

2.4 Europe

2.4.1 Biotechnology industry

2.5 Asia- Pacific region

2.5.1 Biotechnology Industry

2.6 References

3. Major Players

3.1 Introduction

3.2 Novartis

3.3 Amgen

3.4 Genentech

3.5 Genzyme

3.6 Gilead Sciences

3.7 Biogen Idec

3.8 MedImmune Inc

3.9 Invitrogen

3.10 Merck Serono

3.11 Millennium Pharmaceutical Inc

3.12 References

4. Mergers and Acquisitions

4.1 Introduction

4.2 Major Disclosed Deals

4.3 Undisclosed Deals

4.4 Some Major Deals

4.5 Trends in the deals

4.6 References

5. Outlook

5.1 References

LIST OF FIGURES

Figure 1.1: Biotech Industry Revenues, 2002-2006

Figure 1.2: Global Revenue Break-up, 2006

Figure 1.3: Global Biotech Industry Net loss, 2002-2006 Figure 1.4: Global R&D Expenditure, 2002-2006

Figure 1.5: Companies in Biotech Industry, 2002-2006

Figure 1.6: Biotech Financing, 2002-2006

Figure 2.1: Global Real GDP Growth (2005-06)

Figure 2.2: Real GDP Growth Rate in the US (2005-06)

Figure 2.3: Real GDP Growth Rate in Canada (2005-06)

Figure 2.4: Real GDP Growth Rate in European Union (2005-06)

Figure 2.5: Real GDP Growth Rate in Japan (2005-06)

Figure 2.6: Real GDP Growth Rate in India (2005-06)

Figure 2.7: Real GDP Growth Rate in China (2005-06)

Figure 2.8: Major regions of Biotech Industry 2002- 2006

Figure 2.9: North American Biotech Revenue, 2002-2006

Figure 2.10: North American R&D Expenditure, 2002-2006

Figure 2.11: Biotech Companies in North America, 2002-2006

Figure 2.12: European Biotech Revenue, 2002-2006

Figure 2.13: Biotech Companies in Europe, 2002-2006 Figure 2.14: R&D Investment in Europe, 2002-2006

Figure 2.15: Biotech Revenue in Asia-Pacific, 2002-2006

Figure 2.16: Biotech Companies in Asia-Pacific, 2002-2006

Figure 2.17: R&D expenditure in Asia-Pacific, 2002-2006

LIST OF TABLES

Table 1.1: Major IPOs during 2006

Table 1.2: Major venture financings during 2006

Table 1.3: Selected partnering transactions during 2006

Table 1.4: Major drugs approved by FDA during 2006

Table 1.5: Major biotech drugs in pipeline (2006)

Table 1.6: Some important government R&D funding, 2006

Table 2.1: Major companies in North America

Table 2.3: Major European Companies 2006

Table 3.1: Top 10 Biotechnology Companies, 2006

Table 3.2: Novartis 2005- 2006

Table 3.3: Amgen 2005- 2006

Table 3.4: Genentech 2005-2006

Table 3.5: Genzyme 2005-2006

Table 3.6: Gilead Sciences 2005-2006

Table 3.7: Biogen Idec 2005 - 2006

Table 3.8: MedImmune 2005 - 2006

Table 3.9: Invitrogen 2005-2006

Table 3.10: Merck Serono 2005- 2006

Table 3.11: Millennium 2005 - 2006

Table 4.1: Major deals announced/completed 2006

Table 4.2: Undisclosed deals 2006

Abstract

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.